Health and Me

Riya Baibhawi

New Study Shows Dramatic Improvements In Heart Failure Treatment Across US Hospitals

<span><a href="https://www.healthandme.com/health/heart-failure">Heart failure</a></span> continues to pose a major health threat in the <span>United States</span>, with approximately 6.7 million adults currently living with the condition. Alarming projections suggest that this number could climb to more than 8 million by 2030.

However, a promising new analysis published in Circulation: Heart Failure reveals that hospitals involved in the American Heart Association’s multiregional IMPLEMENT-HF initiative have significantly improved their adherence to guideline-directed medical therapy for patients with heart failure with reduced ejection fraction (HFrEF)—the most prevalent form of heart failure.

Launched in 2021, the American Heart Association’s three-year quality improvement initiative was designed to drive the uptake of quadruple medical therapy and incorporate assessments of patients’ health-related social needs into standard care. This quadruple therapy includes a combination of four proven, evidence-based drugs that reduce mortality: angiotensin receptor–neprilysin inhibitor (ARNI), evidence-based specific β-blocker (BB), mineralocorticoid antagonist (MRA), and sodium-glucose cotransporter 2 inhibitor (SGLT2i).

The initiative built upon the Association’s long-running Get With The Guidelines® - Heart Failure program and involved over 100 hospitals nationwide. The latest study, drawing on data from more than 43,000 patients across 67 participating hospitals, highlighted several key outcomes:

The use of all four recommended drug classes for HFrEF patients increased from 4.7% to 44.6% at hospital discharge and from 0% to 44.8% within 30 days after discharge.

The improvement in care was observed consistently across race, ethnicity, and gender.

Hospitals also made significant strides in implementing tools to assess patients’ social needs, marking a vital step toward equitable heart failure care.

"This initiative represents an important leap forward in closing the treatment gap in heart failure," said Dr. Andrew Sauer, a volunteer with the American Heart Association, lead author of the study, and cardiologist at Saint Luke’s Mid America Heart Institute in Kansas City. "By supporting collaborative learning and leveraging real-time data, IMPLEMENT-HF enabled hospitals to better serve patients in varied communities."

HFrEF accounts for nearly half of all heart failure hospitalisations and is associated with a grim five-year mortality rate of 75%. Although clinical trials have long demonstrated that quadruple therapy can significantly enhance survival, its adoption has remained frustratingly low across the U.S., especially among underserved and underrepresented populations.

The IMPLEMENT-HF initiative created a collaborative “all-teach, all-learn” environment that empowered participating hospitals to identify care gaps, share effective practices, and monitor outcomes at both the local and regional levels.

The impressive results underscore the value of collaboration in healthcare. “The improvements we’ve seen through IMPLEMENT-HF highlight the power of teamwork,” the American Heart Association said in a statement. “We remain committed to transforming systems of care to ensure every person—regardless of where they live—has access to the highest standard of heart failure treatment."

Health Conditions A-Z

health

Heart Health

associations

Heart Failure

Us HEALTH NEWS

uNITED STATES

NHS Prompts People To Watch Out For This Summer Skin Sign - 'Call Emergency Services Immediately'

Night Owls Vs Early Birds - Your Genetics Could Be The Reason Why You Are A Morning Person

World Lung Cancer Day 2025: Why You Should NOT Ignore A Recurring Cough? Danger Of Overlooking Early Symptoms

Health News

What Should Fitness Look Like For A 13-18 Year Old

Food For Diabetes: What Should A Diabetic Diet Contain

You Don’t Always Need Weights For Strength Training

Feel Sleepy After Lunches - Light And Healthy Office Lunches

Positive Thinking Practice – How Does It Help You?

MIND Diet – Is This A Healthy Diet Or Another Trend?

Yoga Prop Essentials To Improve Your Exercise Session

Should Potatoes Be The Part Of A Healthy Diet?

Best And Worst Foods To Lower Blood Pressure

Low-Impact Cardio Workouts You Should Try

10 Healthy Pasta Salad Dressing For Weight Loss

Breathing Exercise You Should Do To Relieve Stress

Headache vs. Migraine: Difference Explained In 60 Seconds

High Carb Foods That Are Actually Healthy

How Many Times Do You Need To Wash Your Face?

Hypothyroidism Diet – What To Eat And What You Should Avoid

Stretches To Relieve Leg Pain And Numbness After Sitting For Too Long

No-Cook Healthy Meals For Lazy Days At Home

Easy Breakfast Options To Try During Calorie Deficit

How To Stop Muscle Cramps Immediately

Why You Should Go For An Anti-Inflammatory Diet

Foods To Lower Cortisol Levels In Your Body

High-Fiber Dips You Can Make At Home For The Week

Weekend Warrior Exercises To Makeup For Stressful Week

Experiencing Headaches At Word? Natural Remedies To Try

Yoga Poses That Enhance Digestion

Health Benefits of Walking Backwards

No Eggs? Egg-Alternatives You Can Add To Your Diet

Savory And Smart Ways To Add Broccoli To Your Diet

Calorie Burning Habits That Can Help You Shed Extra Pounds

Yoga Poses That Can Help With Bloating

Fiber-Rich Oatmeal Dishes You Can Have For Breakfast

Signs You Must Visit A Doctor For Your Back Pain

Avocado Meal Prep Ideas To Increase Healthy Fat In Your Diet

Arm Exercises You Can Do At Home

Quick-Office Lunches That Can Keep You Full-Longer

How Increased Screen Time Affects Children's Health

Homemade Recipe To Make Protein-Rich Pancakes With Healthy Alternatives

Push-Up Variations You Can Do At Home

Common Mistakes Running Mistakes People Make

Heart failure continues to pose a major health threat in the United States, with approximately 6.7 million adults currently living with the condition. Alarming projections suggest that this number could climb to more than 8 million by 2030.However, a promising new analysis published in Circulation: Heart Failure reveals that hospitals involved in the American Heart Association’s multiregional IMPLEMENT-HF initiative have significantly improved their adherence to guideline-directed medical therapy for patients with heart failure with reduced ejection fraction (HFrEF)—the most prevalent form of heart failure.Launched in 2021, the American Heart Association’s three-year quality improvement initiative was designed to drive the uptake of quadruple medical therapy and incorporate assessments of patients’ health-related social needs into standard care. This quadruple therapy includes a combination of four proven, evidence-based drugs that reduce mortality: angiotensin receptor–neprilysin inhibitor (ARNI), evidence-based specific β-blocker (BB), mineralocorticoid antagonist (MRA), and sodium-glucose cotransporter 2 inhibitor (SGLT2i).The initiative built upon the Association’s long-running Get With The Guidelines® - Heart Failure program and involved over 100 hospitals nationwide. The latest study, drawing on data from more than 43,000 patients across 67 participating hospitals, highlighted several key outcomes:The use of all four recommended drug classes for HFrEF patients increased from 4.7% to 44.6% at hospital discharge and from 0% to 44.8% within 30 days after discharge.The improvement in care was observed consistently across race, ethnicity, and gender.Hospitals also made significant strides in implementing tools to assess patients’ social needs, marking a vital step toward equitable heart failure care."This initiative represents an important leap forward in closing the treatment gap in heart failure," said Dr. Andrew Sauer, a volunteer with the American Heart Association, lead author of the study, and cardiologist at Saint Luke’s Mid America Heart Institute in Kansas City. "By supporting collaborative learning and leveraging real-time data, IMPLEMENT-HF enabled hospitals to better serve patients in varied communities."HFrEF accounts for nearly half of all heart failure hospitalisations and is associated with a grim five-year mortality rate of 75%. Although clinical trials have long demonstrated that quadruple therapy can significantly enhance survival, its adoption has remained frustratingly low across the U.S., especially among underserved and underrepresented populations.The IMPLEMENT-HF initiative created a collaborative “all-teach, all-learn” environment that empowered participating hospitals to identify care gaps, share effective practices, and monitor outcomes at both the local and regional levels.The impressive results underscore the value of collaboration in healthcare. “The improvements we’ve seen through IMPLEMENT-HF highlight the power of teamwork,” the American Heart Association said in a statement. “We remain committed to transforming systems of care to ensure every person—regardless of where they live—has access to the highest standard of heart failure treatment."

new study shows dramatic improvements in heart failure treatment across us hospitals

Tanya Dutt

Not O, Not AB— This Indian Woman Has A Rare Blood Type 'CRIB' With No Matches Worldwide

Health & Wellness

Medical Memoir: Before COVID, Hepatitis Was The Mystery Virus That Haunted Generations

medical memoir: before covid, hepatitis was the mystery virus that haunted generations

Hepatitis A To E: How Each Virus Affects Your Liver?

hepatitis a to e: how each virus affects your liver?

Hepatitis C in Children: What You Need to Know About Silent Symptoms, Hidden Risks, and Lifesaving Early Action

hepatitis c in children: what you need to know about silent symptoms, hidden risks, and lifesaving early action

What Is That One Thing That Makes Hepatitis So Dangerous?

what is that one thing that makes hepatitis so dangerous?

In what is being hailed as a groundbreaking moment in global transfusion medicine, a 38-year-old woman from Karnataka, India, has been identified as the first known carrier of a previously undocumented human blood group, now officially named CRIB. This unprecedented finding came to light when she was admitted to R.L. Jalappa Hospital in Kolar for heart surgery in 2023.

Though she was originally typed as O-positive, her blood didn’t behave like it. It reacted with every test sample available in the lab—something known as being panreactive. That raised immediate red flags among her physicians. No compatible donor could be found, even among 20 of her closest family members. Despite the risk, the surgical team completed her cardiac procedure without a transfusion—a decision that would later prove critical in her survival and in medical history.

What followed was a medical investigation that spanned continents. Her blood sample was sent to the International Blood Group Reference Laboratory (IBGRL) in Bristol, UK—one of the world’s leading institutions in blood group identification. There, a team of transfusion scientists spent 10 months conducting molecular and serological analyses to crack the case.

Also Read: <a href="https://www.healthandme.com/health-news/james-van-der-beek-shares-health-update-after-stage-3-colorectal-cancer-diagnosis-article-152377963" data-type="tilCustomLink" target="_blank">James Van Der Beek Shares Health Update After Stage 3 Colorectal Cancer Diagnosis</a>

Finally, they concluded that her blood carried an unknown antigen—a marker on red blood cells that typically determines compatibility for transfusions. The antigen didn’t match anything in the 43 existing blood group systems recognized by the International Society of Blood Transfusion (ISBT).

A new antigen was identified within the Cromer blood group system, which involves proteins called decay-accelerating factor (DAF) on red cells. To honor the origin of the discovery, scientists named the antigen CRIB, an acronym combining Cromer, India, and Bengaluru.

<h2>What Is the <span rel="noindex">CRIB Blood Group</span>?</h2>

The CRIB blood group represents a rare antigen profile within the Cromer system. In most people, antigens in this group are present on DAF proteins. But in the CRIB case, the woman lacked a high-prevalence antigen commonly found in the general population, causing her immune system to react to every available donor blood type—even O-positive.

This made the woman’s blood functionally unique. Anyone with this blood type would need extremely rare, CRIB-negative blood in the case of transfusion—currently, there’s no known matching donor worldwide.

This isn’t just a medical oddity—it has far-reaching consequences for how we approach blood donation, transfusion safety, and immunogenetics.

The CRIB blood group challenges conventional systems used for blood typing and compatibility. It underscores how standard blood typing is still incomplete, and how gaps in our understanding can be dangerous—especially in emergency surgeries or during pregnancy.

<h2>How Is This Blood Type Discovery Affect Pregnancy and Fetal Health?</h2>

The discovery of CRIB has serious implications for fetal medicine. Similar to how Rh incompatibility can lead to Hemolytic Disease of the Fetus and Newborn (HDFN), CRIB-positive mothers might develop antibodies that attack the fetus’s red blood cells—if the baby inherits incompatible antigens.

Detecting CRIB in expectant mothers could therefore become critical in preventing miscarriage or fetal complications.

India’s diverse gene pool has previously produced rare blood group discoveries, including INRA (Indian Rare Antigen), first identified in 2017. With CRIB now officially recognised by ISBT, it marks India’s second major contribution to global transfusion science in under a decade.

This elevates the importance of developing a national rare blood registry, and investing in genetic blood screening—not just for patients, but for potential donors.

<h2>What Is The Science Behind the Cromer Group?</h2>

The Cromer blood group system is one of the more obscure and less commonly tested classifications in blood science. It involves antigens located on the DAF (decay-accelerating factor), which protects blood cells from immune destruction. Variants in these antigens can cause unexpected immune reactions during transfusions.

CRIB appears to represent a novel Cromer antigen—meaning it doesn’t behave like any of the previously documented ones. This puts it in a category of what transfusion scientists call high-prevalence antigen absences, where even a single unit of compatible blood can be hard—or impossible—to find.

In an effort to find a compatible blood donor, doctors collected samples from 20 of her family members. None matched. This confirmed that the antigen pattern was not only rare—it was potentially unique.

The case was handled with meticulous care. According to Dr. Ankit Mathur from the Rotary Bangalore TTK Blood Centre, “Her blood was panreactive, incompatible with all test samples. Recognising this as a possible case of a rare or unknown blood type, we worked closely with international experts and managed the case without transfusion.” Now that CRIB has been added to the official ISBT database, transfusion scientists across the world are advocating for:

<ul><li>Development of CRIB-specific antibody screening kits</li><li>International rare blood registries to flag potential future donors</li><li>Greater investment in genetic blood typing, especially in populations with diverse ancestry</li><li>Training healthcare professionals to recognise and manage panreactive or atypical cases earlier</li></ul>

The discovery of CRIB is more than a scientific milestone—it’s a reminder of how individual cases can rewrite medical textbooks. One woman’s unusual blood has now become a catalyst for change in how we view transfusion safety, genetics, and global healthcare cooperation.

For now, she remains the only known person in the world with the CRIB blood group but her case has opened the door to more discoveries and potentially, more lives saved.

crib blood group

rarest blood type

bengaluru woman blood news

rare blood discovery india

crib blood meaning

rare blood group types

unique blood group crib

In what is being hailed as a groundbreaking moment in global transfusion medicine, a 38-year-old woman from Karnataka, India, has been identified as the first known carrier of a previously undocumented human blood group, now officially named CRIB. This unprecedented finding came to light when she was admitted to R.L. Jalappa Hospital in Kolar for heart surgery in 2023.Though she was originally typed as O-positive, her blood didn’t behave like it. It reacted with every test sample available in the lab—something known as being panreactive. That raised immediate red flags among her physicians. No compatible donor could be found, even among 20 of her closest family members. Despite the risk, the surgical team completed her cardiac procedure without a transfusion—a decision that would later prove critical in her survival and in medical history.What followed was a medical investigation that spanned continents. Her blood sample was sent to the International Blood Group Reference Laboratory (IBGRL) in Bristol, UK—one of the world’s leading institutions in blood group identification. There, a team of transfusion scientists spent 10 months conducting molecular and serological analyses to crack the case.Also Read: James Van Der Beek Shares Health Update After Stage 3 Colorectal Cancer DiagnosisFinally, they concluded that her blood carried an unknown antigen—a marker on red blood cells that typically determines compatibility for transfusions. The antigen didn’t match anything in the 43 existing blood group systems recognized by the International Society of Blood Transfusion (ISBT).A new antigen was identified within the Cromer blood group system, which involves proteins called decay-accelerating factor (DAF) on red cells. To honor the origin of the discovery, scientists named the antigen CRIB, an acronym combining Cromer, India, and Bengaluru.What Is the CRIB Blood Group?The CRIB blood group represents a rare antigen profile within the Cromer system. In most people, antigens in this group are present on DAF proteins. But in the CRIB case, the woman lacked a high-prevalence antigen commonly found in the general population, causing her immune system to react to every available donor blood type—even O-positive.This made the woman’s blood functionally unique. Anyone with this blood type would need extremely rare, CRIB-negative blood in the case of transfusion—currently, there’s no known matching donor worldwide.This isn’t just a medical oddity—it has far-reaching consequences for how we approach blood donation, transfusion safety, and immunogenetics.The CRIB blood group challenges conventional systems used for blood typing and compatibility. It underscores how standard blood typing is still incomplete, and how gaps in our understanding can be dangerous—especially in emergency surgeries or during pregnancy.How Is This Blood Type Discovery Affect Pregnancy and Fetal Health?The discovery of CRIB has serious implications for fetal medicine. Similar to how Rh incompatibility can lead to Hemolytic Disease of the Fetus and Newborn (HDFN), CRIB-positive mothers might develop antibodies that attack the fetus’s red blood cells—if the baby inherits incompatible antigens.Detecting CRIB in expectant mothers could therefore become critical in preventing miscarriage or fetal complications.India’s diverse gene pool has previously produced rare blood group discoveries, including INRA (Indian Rare Antigen), first identified in 2017. With CRIB now officially recognised by ISBT, it marks India’s second major contribution to global transfusion science in under a decade.This elevates the importance of developing a national rare blood registry, and investing in genetic blood screening—not just for patients, but for potential donors.What Is The Science Behind the Cromer Group?The Cromer blood group system is one of the more obscure and less commonly tested classifications in blood science. It involves antigens located on the DAF (decay-accelerating factor), which protects blood cells from immune destruction. Variants in these antigens can cause unexpected immune reactions during transfusions.CRIB appears to represent a novel Cromer antigen—meaning it doesn’t behave like any of the previously documented ones. This puts it in a category of what transfusion scientists call high-prevalence antigen absences, where even a single unit of compatible blood can be hard—or impossible—to find.In an effort to find a compatible blood donor, doctors collected samples from 20 of her family members. None matched. This confirmed that the antigen pattern was not only rare—it was potentially unique.The case was handled with meticulous care. According to Dr. Ankit Mathur from the Rotary Bangalore TTK Blood Centre, “Her blood was panreactive, incompatible with all test samples. Recognising this as a possible case of a rare or unknown blood type, we worked closely with international experts and managed the case without transfusion.” Now that CRIB has been added to the official ISBT database, transfusion scientists across the world are advocating for:Development of CRIB-specific antibody screening kitsInternational rare blood registries to flag potential future donorsGreater investment in genetic blood typing, especially in populations with diverse ancestryTraining healthcare professionals to recognise and manage panreactive or atypical cases earlierThe discovery of CRIB is more than a scientific milestone—it’s a reminder of how individual cases can rewrite medical textbooks. One woman’s unusual blood has now become a catalyst for change in how we view transfusion safety, genetics, and global healthcare cooperation.For now, she remains the only known person in the world with the CRIB blood group but her case has opened the door to more discoveries and potentially, more lives saved.

not o, not ab— this indian woman has a rare blood type 'crib' with no matches worldwide

Ishita Roy

James Van Der Beek Shares Health Update After Stage 3 Colorectal Cancer Diagnosis

What Is Acute Necrotizing Encephalopathy? The Rare Brain Swelling In Kids That Is Linked To Flu

what is acute necrotizing encephalopathy? the rare brain swelling in kids that is linked to flu

Firefighters May Be Putting Their Lives At Risk In More Ways Than We Realize - Study Finds

firefighters may be putting their lives at risk in more ways than we realize - study finds

Science of Hair Serums: Do They Really Repair Damaged Hair?

science of hair serums: do they really repair damaged hair?

<span>James Van Der Beek</span> says his life will never be the same again. Diagnosed with stage 3 <span>colorectal cancer</span> in August 2023, the Dawson’s Creek and Varsity Blues actor is now facing the kind of life transformation that goes far beyond Hollywood scripts.

“I’m just on the journey,” the 48-year-old told Today.com in a candid interview. “It's a process. It'll probably be a process for the rest of my life."

For Van Der Beek, living with <span>cancer</span> isn’t just about treatment. It’s become a full-time job, one that’s required a complete overhaul of his lifestyle. From modifying his diet to rethinking how he exercises and rests, the actor has embraced a slower, more intentional way of living.

“The most important thing,” Van Der Beek shared, “is to find the beauty of just taking things a little bit more slowly and prioritizing rest, and really allowing that to be the job.”

His perspective is reflective of someone who has been forced to confront mortality. In an emotional Instagram post in March, the actor said, “I had to come nose to nose with death.”

During treatment, he had to step back from his role as a father and husband. “I could no longer be a father who could pick up his kids and put them to bed... I could not be a provider because I wasn't working."

Yet in the quiet moments of stillness, he found something unexpected: spiritual clarity. “I meditated and the answer came through. I am worthy of God's love, simply because I exist. And if I'm worthy of God's love, shouldn't I also be worthy of my own?”

<h4>Encouraging Others to Get Screened</h4>

Van Der Beek, who was screened at age 46, is now encouraging others to get checked earlier. He admitted he was unaware that the recommended age for colorectal cancer screenings had been lowered to 45.

“I thought I was way ahead of the game,” he said. “I ate as well as I could. I was healthy. I was in amazing cardiovascular shape. There was no reason in my mind that I should have gotten a positive diagnosis.”

His message is clear: even those who feel and look healthy aren’t immune, and early detection can be life-saving.

Despite everything, Van Der Beek has been finding joy and even normalcy through work. He recently filmed for the upcoming Legally Blonde prequel series Elle, calling the experience a much-needed escape.

"The greatest thing about work is cancer doesn't exist between action and cut," he said. “It was fun to drop in and just have a blast… It’s such a great cast, a great production, and everybody out there is really talented.”

<h4>A Healing Phase and a Family Anchor</h4>

In March, he gave Extra an update from his Texas ranch, where he lives with his wife Kimberly and their six children, Olivia (14), Joshua (13), Annabel (11), Emilia (9), Gwendolyn (7), and Jeremiah (3). Van Der Beek said he’s now in a “healing portal,” adding, “I feel like I can see the finish line.”

Earlier that month, he made his debut as the Griffin on The Masked Singer, a role that offered unexpected emotional catharsis. “To be able to put on the mask and connect with an audience without [my diagnosis] being a part of the equation was actually a really beautiful thing,” he said.

james van der beek

james van der beek health

health news

health news usa

cancer

colorectal cancer

James Van Der Beek says his life will never be the same again. Diagnosed with stage 3 colorectal cancer in August 2023, the Dawson’s Creek and Varsity Blues actor is now facing the kind of life transformation that goes far beyond Hollywood scripts.“I’m just on the journey,” the 48-year-old told Today.com in a candid interview. “It's a process. It'll probably be a process for the rest of my life."For Van Der Beek, living with cancer isn’t just about treatment. It’s become a full-time job, one that’s required a complete overhaul of his lifestyle. From modifying his diet to rethinking how he exercises and rests, the actor has embraced a slower, more intentional way of living.Finding Peace in Slowing Down“The most important thing,” Van Der Beek shared, “is to find the beauty of just taking things a little bit more slowly and prioritizing rest, and really allowing that to be the job.”His perspective is reflective of someone who has been forced to confront mortality. In an emotional Instagram post in March, the actor said, “I had to come nose to nose with death.”          View this post on Instagram            A post shared by James Van Der Beek (@vanderjames)]]> During treatment, he had to step back from his role as a father and husband. “I could no longer be a father who could pick up his kids and put them to bed... I could not be a provider because I wasn't working."Yet in the quiet moments of stillness, he found something unexpected: spiritual clarity. “I meditated and the answer came through. I am worthy of God's love, simply because I exist. And if I'm worthy of God's love, shouldn't I also be worthy of my own?”Encouraging Others to Get ScreenedVan Der Beek, who was screened at age 46, is now encouraging others to get checked earlier. He admitted he was unaware that the recommended age for colorectal cancer screenings had been lowered to 45.“I thought I was way ahead of the game,” he said. “I ate as well as I could. I was healthy. I was in amazing cardiovascular shape. There was no reason in my mind that I should have gotten a positive diagnosis.”His message is clear: even those who feel and look healthy aren’t immune, and early detection can be life-saving.Back on Set and Grateful for ItDespite everything, Van Der Beek has been finding joy and even normalcy through work. He recently filmed for the upcoming Legally Blonde prequel series Elle, calling the experience a much-needed escape."The greatest thing about work is cancer doesn't exist between action and cut," he said. “It was fun to drop in and just have a blast… It’s such a great cast, a great production, and everybody out there is really talented.”A Healing Phase and a Family AnchorIn March, he gave Extra an update from his Texas ranch, where he lives with his wife Kimberly and their six children, Olivia (14), Joshua (13), Annabel (11), Emilia (9), Gwendolyn (7), and Jeremiah (3). Van Der Beek said he’s now in a “healing portal,” adding, “I feel like I can see the finish line.”Earlier that month, he made his debut as the Griffin on The Masked Singer, a role that offered unexpected emotional catharsis. “To be able to put on the mask and connect with an audience without [my diagnosis] being a part of the equation was actually a really beautiful thing,” he said.

james van der beek shares health update after stage 3 colorectal cancer diagnosis

RFK Jr. Is Leaving Behind 'Rigorous Science', Say Ousted Vaccine Panel Members

Who Is Susan Monarez? The New CDC Director Confirmed By The US Senate

who is susan monarez? the new cdc director confirmed by the us senate

26 US States Are Witnessing A Spike In The New COVID-19 Variant Cases: How To Keep Your Kids Safe This Summer?

26 us states are witnessing a spike in the new covid-19 variant cases: how to keep your kids safe this summer?

Last month, 17 top public health experts were abruptly removed from the U.S. Advisory Committee on Immunization Practices (ACIP), the group historically responsible for setting national vaccine guidelines. The move came directly from U.S. Health Secretary Robert F. <span>Kennedy</span> Jr., who <a href="https://www.healthandme.com/health-news/rfk-jr-removes-entire-cdc-vaccine-advisory-committee-article-151823769" data-type="tilCustomLink">dismissed </a>the entire panel, accusing them of being too closely tied to vaccine manufacturers and too quick to approve vaccines without scrutiny.

In their place, Kennedy <a href="https://www.healthandme.com/health-news/kennedy-names-new-vaccine-advisers-among-whom-are-anti-vaxxers-and-those-who-spread-misinformation-after-ousting-the-entire-panel-article-151879801" data-type="tilCustomLink">appointed </a>several individuals known for their skepticism toward vaccines, a controversial decision that has sparked concern among the medical community.

<strong>READ MORE ON: <a href="https://www.healthandme.com/health-news/rfk-jr-removes-entire-cdc-vaccine-advisory-committee-article-151823769" data-type="tilCustomLink">RFK Jr. Removes Entire CDC Vaccine Advisory Committee</a></strong>

<strong><a href="https://www.healthandme.com/health-news/kennedy-names-new-vaccine-advisers-among-whom-are-anti-vaxxers-and-those-who-spread-misinformation-after-ousting-the-entire-panel-article-151879801" data-type="tilCustomLink">Kennedy Names New Vaccine Advisers Among Whom Are Anti-Vaxxers And Those Who Spread Misinformation</a></strong>

<h4>“A Travesty” of a First Meeting</h4>

In a strongly worded commentary published in the <em>N</em><em>ew England Journal of Medicine</em> this week, the ousted experts criticized what they say is a dangerous shift in how vaccine policy is being handled. According to the former committee members, the new ACIP lacks <strong>rigorous scientific </strong>review and open discussion.

They pointed to the new committee’s first meeting in June as a troubling example. 

The session included a presentation from a known anti-vaccine advocate warning against thimerosal, a preservative used in some flu vaccines, despite longstanding studies showing no link between thimerosal and neurodevelopmental disorders. Strikingly, the new panel did not hear from Centers for Disease Control and Prevention (CDC) scientists who could have presented data debunking the concerns.

Despite acknowledging the lack of evidence against <a href="https://www.healthandme.com/health-news/rfk-jr-orders-thimerosal-removed-from-all-us-flu-shots-article-152334591" data-type="tilCustomLink">thimerosal</a>, the committee still voted to recommend removing it from vaccines.

<strong>ALSO READ: <a href="https://www.healthandme.com/health-news/rfk-jr-orders-thimerosal-removed-from-all-us-flu-shots-article-152334591" data-type="tilCustomLink">RFK Jr. Orders Thimerosal Removed From All US Flu Shots</a></strong>

“That meeting was a <strong>travesty</strong>, honestly,” said Dr. Yvonne Maldonado, a pediatric infectious disease expert from Stanford University and a former ACIP member, as reported by AP.

This isn’t the first time Kennedy’s decisions have raised eyebrows. 

In May, he made headlines for halting the federal recommendation of COVID-19 vaccines for healthy children and pregnant women. The fired experts addressed this in an earlier essay published in the Journal of the American Medical Association, calling Kennedy’s choices “destabilizing.”

Now, their latest commentary goes further, warning that the current path could lead to long-term damage to public health. They argue that Kennedy and his newly selected panel are dismantling a once-trusted system that upheld science-based, unbiased vaccine guidance for decades.

Recognizing the challenge of restoring the former ACIP structure, the ousted experts proposed new ideas for preserving trustworthy vaccine policy. They suggest forming an alternative committee, potentially independent from the federal government, to provide reliable recommendations.

“No viable pathway exists to fully replace the prior trusted and unbiased ACIP structure and process,” they wrote. “Instead, the alternatives must focus on limiting the damage to vaccination policy in the United States.”

Other suggestions included encouraging leading professional health organizations to collaborate on unified recommendations, or establishing an external group to audit ACIP’s guidance. However, the experts admitted that such efforts face major hurdles, especially regarding access to government-held data.

<strong>YOU MAY LIKE TO READ: <a href="https://www.healthandme.com/health-news/rfk-hires-autism-skeptic-to-look-into-cdc-autism-data-article-151899045" data-type="tilCustomLink">RFK Hires Autism Skeptic To Look Into CDC Autism Data</a></strong>

<h4>Insurance Coverage and Access at Risk</h4>One major concern with shifting vaccine policy outside federal guidance is how insurance providers will respond. Would insurers cover vaccines recommended by independent groups but not by the ACIP?

Noel Brewer, a former committee member from the University of North Carolina, warned that insurers might selectively cover vaccines based on short-term cost savings. For example, the flu shot, which helps avoid immediate healthcare expenses, might be approved, while longer-term preventive vaccines, like the HPV shot, could be left out.

“That’s the danger,” Brewer said. “Vaccines that prevent future cancers might not make the cut.”

Kennedy’s actions have not gone unnoticed in Congress. During a recent House hearing, Democratic lawmakers grilled him about his rapid and sweeping changes to national vaccine policy. So far, the U.S. Department of Health and Human Services has not responded to media inquiries regarding the criticism or the experts’ proposed solutions.

<strong>READ MORE: <a href="https://www.healthandme.com/health-news/rfk-jr-s-vaccine-panel-votes-against-flu-shot-preservative-all-about-the-controversial-thimerosal-ingredient-article-152167755" data-type="tilCustomLink">RFK Jr.’s Vaccine Panel Votes Against Flu Shot Preservative: All About The Controversial Thimerosal Ingredient</a></strong>

rfk jr

us news

us health news

vaccine advisory committee

kennedy

Last month, 17 top public health experts were abruptly removed from the U.S. Advisory Committee on Immunization Practices (ACIP), the group historically responsible for setting national vaccine guidelines. The move came directly from U.S. Health Secretary Robert F. Kennedy Jr., who dismissed the entire panel, accusing them of being too closely tied to vaccine manufacturers and too quick to approve vaccines without scrutiny.In their place, Kennedy appointed several individuals known for their skepticism toward vaccines, a controversial decision that has sparked concern among the medical community.READ MORE ON: RFK Jr. Removes Entire CDC Vaccine Advisory CommitteeKennedy Names New Vaccine Advisers Among Whom Are Anti-Vaxxers And Those Who Spread Misinformation“A Travesty” of a First MeetingIn a strongly worded commentary published in the New England Journal of Medicine this week, the ousted experts criticized what they say is a dangerous shift in how vaccine policy is being handled. According to the former committee members, the new ACIP lacks rigorous scientific review and open discussion.They pointed to the new committee’s first meeting in June as a troubling example. The session included a presentation from a known anti-vaccine advocate warning against thimerosal, a preservative used in some flu vaccines, despite longstanding studies showing no link between thimerosal and neurodevelopmental disorders. Strikingly, the new panel did not hear from Centers for Disease Control and Prevention (CDC) scientists who could have presented data debunking the concerns.Despite acknowledging the lack of evidence against thimerosal, the committee still voted to recommend removing it from vaccines.ALSO READ: RFK Jr. Orders Thimerosal Removed From All US Flu Shots“That meeting was a travesty, honestly,” said Dr. Yvonne Maldonado, a pediatric infectious disease expert from Stanford University and a former ACIP member, as reported by AP.A Pattern of DestabilizationThis isn’t the first time Kennedy’s decisions have raised eyebrows. In May, he made headlines for halting the federal recommendation of COVID-19 vaccines for healthy children and pregnant women. The fired experts addressed this in an earlier essay published in the Journal of the American Medical Association, calling Kennedy’s choices “destabilizing.”Now, their latest commentary goes further, warning that the current path could lead to long-term damage to public health. They argue that Kennedy and his newly selected panel are dismantling a once-trusted system that upheld science-based, unbiased vaccine guidance for decades.Proposing a Way ForwardRecognizing the challenge of restoring the former ACIP structure, the ousted experts proposed new ideas for preserving trustworthy vaccine policy. They suggest forming an alternative committee, potentially independent from the federal government, to provide reliable recommendations.“No viable pathway exists to fully replace the prior trusted and unbiased ACIP structure and process,” they wrote. “Instead, the alternatives must focus on limiting the damage to vaccination policy in the United States.”Other suggestions included encouraging leading professional health organizations to collaborate on unified recommendations, or establishing an external group to audit ACIP’s guidance. However, the experts admitted that such efforts face major hurdles, especially regarding access to government-held data.YOU MAY LIKE TO READ: RFK Hires Autism Skeptic To Look Into CDC Autism DataInsurance Coverage and Access at RiskOne major concern with shifting vaccine policy outside federal guidance is how insurance providers will respond. Would insurers cover vaccines recommended by independent groups but not by the ACIP?Noel Brewer, a former committee member from the University of North Carolina, warned that insurers might selectively cover vaccines based on short-term cost savings. For example, the flu shot, which helps avoid immediate healthcare expenses, might be approved, while longer-term preventive vaccines, like the HPV shot, could be left out.“That’s the danger,” Brewer said. “Vaccines that prevent future cancers might not make the cut.”A Growing ControversyKennedy’s actions have not gone unnoticed in Congress. During a recent House hearing, Democratic lawmakers grilled him about his rapid and sweeping changes to national vaccine policy. So far, the U.S. Department of Health and Human Services has not responded to media inquiries regarding the criticism or the experts’ proposed solutions.READ MORE: RFK Jr.’s Vaccine Panel Votes Against Flu Shot Preservative: All About The Controversial Thimerosal Ingredient

rfk jr. is leaving behind 'rigorous science', say ousted vaccine panel members

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.